Rickets, Hypophosphatemic clinical trials
The registry lists 10 studies for Rickets, Hypophosphatemic across more than 10 countries. 0 are recruiting or about to start. 4 of them are mainly about Rickets, Hypophosphatemic (how this is decided). Per ClinicalTrials.gov, last updated 2026-08-28. Counting its narrower condition Familial Hypophosphatemic Rickets too: 54 studies, 7 open.
Who runs them
University of Rostock (1) · Yale University (1) · University of Aarhus (1) · Ultragenyx Pharmaceutical Inc (1) · Massachusetts General Hospital (1) · National Institute of Dental and Craniofacial Research (NIDCR) (1) · Assistance Publique - Hôpitaux de Paris (1) · Hospices Civils de Lyon (1)
What is being tested here
Drugs under test in Rickets, Hypophosphatemic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Calcitriol | 0 | 0 | 1 |
| Paricalcitol | 0 | 1 | 1 |
| Burosumab | 0 | 1 | 1 |
| Human Growth Hormone | 0 | 0 | 1 |
Who these studies take
No Rickets, Hypophosphatemic study is recruiting now.
Across all 10 studies, recruiting or not: 50% stop at 75 or younger and 30% at 65; 80% take children; 20% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 10 of 10. search them.
- X-linked Hypophosphatemia Disease Monitoring ProgramActive, not recruitingNCT036515056 countries
- Calcitriol Monotherapy for X-Linked HypophosphatemiaCompletedNCT03748966Early Phase 11 country
- Burosumab and 1-25 (OH) Vitamin D on Human OsteoclastsCompletedNCT041846611 country
- Dental Implants in Patients With X-linked HypophosphatemiaStatus unknownNCT038799151 country
- Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic RicketsCompletedNCT00417612Phase 31 country
- Open Label Trial Assessing Safety and Efficacy of Burosumab (KRN23), in a Patient With ENS and Hypophosphatemic RicketsCompletedNCT03581591Phase 31 country
- Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)TerminatedNCT01748812Phase 11 country
- Milk Products in the Treatment of Hypophosphatemic RicketsCompletedNCT03348644Not applicable1 country
- Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic RicketsCompletedNCT01237288Phase 31 country
- Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic RicketsStatus unknownNCT00473187Phase 11 country